Related Experiment Videos

Comorbidity index was successfully validated among men but not in women

Cristina Rius1, Glòria Pérez, Maica Rodríguez-Sanz

  • 1Public Health Agency of Barcelona, Epidemiology Service, Plaça Lesseps, 1. 08023 Barcelona, Spain. 32284mrg@comb.es

Journal of Clinical Epidemiology
|April 1, 2008
PubMed

Insights

This study validated a comorbidity index for predicting mortality. The index showed good prognostic accuracy in men but requires refinement for women in population-based cohorts.

Area of Science:

  • Epidemiology
  • Biostatistics
  • Gerontology

Background:

  • Comorbidity indices are crucial for predicting patient outcomes.
  • Previous indices require validation in diverse populations.
  • Accurate prognostic tools are essential for healthcare planning.

Purpose of the Study:

  • To validate the prognostic accuracy of a previously developed comorbidity index.
  • To assess the index's calibration and discrimination in a separate population-based cohort.
  • To evaluate the index's performance in both men and women.

Main Methods:

  • The study assessed a comorbidity index's predictive accuracy for mortality.
  • Calibration was evaluated using the Hosmer-Lemeshow (HL) test.
  • Discrimination was analyzed using the area under the receiver operating characteristic curves (ROC).

Main Results:

  • The comorbidity index demonstrated good calibration and discrimination in the development cohort for both sexes.
  • In the validation cohort, good calibration was observed in men (HL=10.1, P=0.43) but not in women (HL=21.4, P=0.01).
  • Discrimination remained consistent in the validation cohort for both men (ROC area=80%) and women (ROC area=78%).

Conclusions:

  • The comorbidity index was successfully validated in a separate population-based cohort for men.
  • The index's prognostic accuracy was not confirmed in women in the validation cohort.
  • Further refinement of the comorbidity index may be needed for equitable application across sexes.
Abstract

Related Concept Videos

Sex Linked Disorders01:43

Sex Linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Odds Ratio01:09

Odds Ratio

The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...